Royalty Pharma plc Class A Ordinary Shares vs Viavi Solutions Inc. Common Stock — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B), while Viavi Solutions Inc. Common Stock trades at $45.46 (market cap $10.85B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.3× Viavi Solutions Inc. Common Stock's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Viavi Solutions Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| RPRX | VIAV | |
|---|---|---|
Market Cap | $25.27B | $10.85B |
Volume | 3,671,183 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $63.96 | $55.33 |
52-Week Low | $35.44 | $12.27 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $32.50B | $10.89B |
Dividend Yield | 1.66% | — |
Trailing returns across standard periods
Latest headlines on both assets
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →